Increased serum acetylcholine receptor α1 subunit protein in anti-acetylcholine receptor antibody-positive myasthenia gravis

J Neuroimmunol. 2020 Feb 15:339:577125. doi: 10.1016/j.jneuroim.2019.577125. Epub 2019 Dec 9.

Abstract

Complement-dependent disruption of motor endplate is detected in anti-acetylcholine receptor (AChR) antibody-positive myasthenia gravis (MG). We measured serum AChR α1 subunit protein levels, which may be associated with neuromuscular damage, in 55 patients with MG (47 were seropositive and 8 were negative) and in 20 controls. Serum AChR α1 subunit protein concentrations were higher in patients with anti-AChR antibody-positive MG than those in controls (P = .04), were negatively correlated with MG activities of daily living score (P = .01), and tended to be higher in ocular MG than in generalized MG. AChR α1 subunit protein elevation may be related to seropositive MG pathogenesis, especially in the ocular type.

Keywords: Anti-acetylcholine receptor antibody; Biomarker; Myasthenia gravis; Neuromuscular junction damage.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Autoantibodies / blood*
  • Biomarkers / blood
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myasthenia Gravis / blood*
  • Myasthenia Gravis / diagnosis*
  • Receptors, Nicotinic / blood*
  • Young Adult

Substances

  • Autoantibodies
  • Biomarkers
  • CHRNA1 protein, human
  • Receptors, Nicotinic